Heights Capital Management, Inc Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Heights Capital Management, Inc
- $375 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
55Shares Held
14.5MCall Options Held
4.9MPut Options Held
29.7K-
Diadema Partners LP Morristown, NJ2.74MShares$1.23 Million0.32% of portfolio
-
Armistice Capital, LLC New York, NY2.69MShares$1.21 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$811,8410.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.49MShares$669,6190.0% of portfolio
-
683 Capital Management, LLC New York, NY1MShares$450,0000.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $9.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...